Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Exports Under The Bolar Exception: A Key Arrow In The Indian Generics Quiver

    India is the largest producer of generic drugs in the world, and thus, it is no surprise that a great deal of patent litigation in India has centred on the manufacture of generics.
    IndiaIntellectual Property
    Obhan Mason
    Obhan Mason
  • Article

    Regulatory Yearly Wrap 2021: Digital Health In India

    Varsha Rajesh, Tanya Kukade, Darren Punnen & Dr. Milind Antani
    IndiaFinance and Banking
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

Medical Devices Classified As Drugs

On 11 February 2020, the Government of India issued a notification declaring that all medical devices are to be classified as drugs from 1 April 2020 under the Drugs and Cosmetics Act, 1940.
IndiaFood, Drugs, Healthcare, Life Sciences
Nexdigm Private Limited
Nexdigm Private Limited
  • Article

    Spotlight: Medical Devices Industry In India

    In "Spotlight" we will be discussing the opportunities and challenges that our clients face in various sectors, in conversation with CXOs.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Asit Mehta & Associates
    Asit Mehta & Associates
  • Article

    Back To The Drawing Board: Indian Courts' Tryst With Public Interest Principle In Pharmaceutical Patent Infringement

    The recent past has seen a few blogposts on how public interest is factored in (or isn't) by courts. A post looking at public interest as viewed in interim injunctions for pharma cases
    IndiaIntellectual Property
    Saikrishna and Associates, Advocates
    Saikrishna and Associates, Advocates
  • Article

    Colour As A Trade Dress In The Pharmaceutical Industry

    The notion of trade dress is defined in Section 2(zb) of the Trademarks Act 1999, which defines a ‘trademark' in broad terms, including shape, packaging, and color combinations...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    COVID-19 Counterfeit Products And Fake Goods – Indian Law Perspective

    As misinformation on COVID-19 continues to spread, there is another more serious threat being dispersed through back trade channels and that is of counterfeit goods either for sale...
    IndiaIntellectual Property
    Kochhar & Co.
    Kochhar & Co.
  • Article

    Patenting Of Genetically Modified Crops In India Vis-À-Vis International Decisions

    India has been following a very strict IP policy which is evident from its recent decision in Novartis case.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Tech Ticker Issue 35: April 2022

    In this edition, we bring you the tug of war between telecom and satellite operators for 5G spectrum. Also uncovering – Tamil Nadu's data policy for good governance, the National Restaurants Association's spat with Swiggy and Zomato, and more!
    IndiaMedia, Telecoms, IT, Entertainment
    Ikigai Law
    Ikigai Law
  • Article

    Rethink. Restructure. Revive. Union Budget 2020

    The Union Budget 2020 has been duly positioned as a game-changer for the country's economy. The finance ministry has a mammoth task of improving GDP, resurrecting the affected sectors, and reviving a debilitating economy overall.
    IndiaTax
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Patent Pool As A Tool To Tackle COVID-19 Pandemic

    Do patent pools facilitate innovation or strangle it? One must evaluate pros and cons before creating or entering patent pools so that one can minimize risks and obtain benefits.
    IndiaIntellectual Property
    InvnTree Intellectual Property Services Pvt. Ltd.
    InvnTree Intellectual Property Services Pvt. Ltd.
  • Article

    Compulsory License Granted To NATCO

    The viewpoint of being able to provide cheap drugs to a population which cannot afford it has started yet another debate in the pharma sector about how drug companies should price the life saving drugs in the developing world.
    IndiaIntellectual Property
    Lex Orbis
    Lex Orbis
  • Article

    Customs Recordation In India: Understanding The Limits Of Border Enforcement Of IPR

    India's customs framework gives intellectual property owners a powerful tool to prevent counterfeit or pirated goods from entering the market.
    IndiaIntellectual Property
    Maheshwari & Co. Advocates & Legal Consultants
    Maheshwari & Co. Advocates & Legal Consultants
  • Article

    Law, Morality, Ethics And Religion-Biological Patents

    From ages human beings have been trying to master the art of Biotechnology, but the 21st century has been seeing something different.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Non-Obviousness/Inventive-Step –The Essential Requirement For Biotechnology Patent Prosecution

    Patent protection plays a crucial role on which the biotechnology industry's tremendous investment in research and development as well as its growth rests.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Experiments With Animals: The Long Road To Preventing Animal Testing In R&D In India

    Over 100 million animals are used in laboratory experiments worldwide every year. These are only estimates; the exact number...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Obhan Mason
    Obhan Mason
  • Article

    Start Up India

    Government of India has announced the START UP India in August 2015. Under "START UP INDIA", the Govt. intends to build a strong eco system for nurturing innovation and start ups in the country ...
    IndiaGovernment, Public Sector
    Infini Juridique
    Infini Juridique
  • Article

    Karnataka's Proposed Good Samaritan And Medical Professional Protection Rules, 2026: A Comprehensive Legal Framework For Emergency Medical Assistance

    The Government of Karnataka has taken a significant step towards enhancing emergency medical care and protecting Good Samaritans through the promulgation of comprehensive rules under the Karnataka Good Samaritan...
    IndiaFood, Drugs, Healthcare, Life Sciences
    IndiaLaw LLP
    IndiaLaw LLP
  • Article

    Exclusive Marketing Rights Revisited In India

    Interest in the repealed exclusive marketing rights provisions has been revived by a Supreme Court ruling which clarifies the effect of the repeal on the litigation of pending and decided applications
    IndiaIntellectual Property
    Anand & Anand
    Anand & Anand
  • Article

    IPO Rejects Patent Application For Xtandi (Prostrate Cancer Drug)

    The India Patent Office in its order issued on 18th November 2016, has denied a patent for the prostate cancer drug sold under the brand name Xtandi (generic name Enzalutamide).
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Showing 261–280 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics